Choate Investment Advisors lifted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.7% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 33,372 shares of the pharmacy operator’s stock after buying an additional 243 shares during the quarter. Choate Investment Advisors’ holdings in Walgreens Boots Alliance were worth $2,613,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of WBA. Hudock Capital Group LLC increased its position in shares of Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 6 shares during the period. Reilly Financial Advisors LLC increased its position in shares of Walgreens Boots Alliance by 7.9% in the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after purchasing an additional 100 shares during the period. Orrstown Financial Services Inc. increased its position in shares of Walgreens Boots Alliance by 14.1% in the second quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 213 shares during the period. Founders Capital Management bought a new position in shares of Walgreens Boots Alliance in the first quarter worth $161,000. Finally, Hanson McClain Inc. increased its position in shares of Walgreens Boots Alliance by 4.6% in the second quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock worth $156,000 after purchasing an additional 87 shares during the period. 63.58% of the stock is owned by institutional investors.
A number of research analysts recently commented on the company. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday. UBS AG restated a “buy” rating and issued a $96.00 price target (down previously from $97.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, August 23rd. Royal Bank Of Canada assumed coverage on Walgreens Boots Alliance in a research report on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price target on the stock. Jefferies Group LLC restated a “buy” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, October 2nd. Finally, Zacks Investment Research upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Monday, October 30th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of “Buy” and an average target price of $87.63.
In other Walgreens Boots Alliance news, Director John Anthony Lederer purchased 20,000 shares of the company’s stock in a transaction on Thursday, October 26th. The shares were purchased at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the purchase, the director now owns 50,000 shares in the company, valued at $3,350,000. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the transaction, the director now directly owns 16,415 shares in the company, valued at $1,105,878.55. The disclosure for this sale can be found here. 13.50% of the stock is owned by insiders.
Walgreens Boots Alliance, Inc. (WBA) opened at $70.37 on Tuesday. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $71,667.88, a P/E ratio of 13.92, a P/E/G ratio of 1.26 and a beta of 1.20. Walgreens Boots Alliance, Inc. has a 12 month low of $63.82 and a 12 month high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, topping the Zacks’ consensus estimate of $1.21 by $0.10. The company had revenue of $30.15 billion for the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.07 earnings per share. analysts predict that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current year.
Walgreens Boots Alliance declared that its Board of Directors has initiated a stock buyback plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company’s board believes its shares are undervalued.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date of this dividend is Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is currently 42.33%.
COPYRIGHT VIOLATION WARNING: “Choate Investment Advisors Boosts Stake in Walgreens Boots Alliance, Inc. (WBA)” was reported by Markets Daily and is the property of of Markets Daily. If you are accessing this article on another publication, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.themarketsdaily.com/2017/11/14/choate-investment-advisors-boosts-stake-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.